{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:02:19Z","timestamp":1793160139431,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-22-0271"],"award-info":[{"award-number":["APVV-22-0271"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA 2\/0131\/24"],"award-info":[{"award-number":["VEGA 2\/0131\/24"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["313011AVG3"],"award-info":[{"award-number":["313011AVG3"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Myocardial infarction (MI) results from the abrupt interruption of coronary blood flow, leading to ischaemia and cardiac tissue necrosis. High mobility group box 1 (HMGB1), a damage-associated molecular pattern, plays a dual role in MI, offering protection or causing damage depending on the cellular redox status, timing of its activity, and location. The aim of this study was to analyse the effects of an anti-HMGB1 protein on certain biochemical parameters of individual myocardial zones, the infarct zone (IZ), injured zone (INZ), and noninfarct zone (NIZ), after MI. Twelve-week-old male WKY rats were randomly divided into 3 experimental groups: 1. control (sham), 2. MI (MI), and 3. MI plus anti-HMGB1 treatment (MI\u2009+\u2009aHMGB1). MI was induced via 20-min ligation of the left descending coronary artery and was followed by reperfusion. Anti-HMGB1 (10\u00a0\u03bcl) was administered before reperfusion. The animals were sacrificed 7\u00a0days later. The plasma levels of the cytokines IL-6 and TNF-\u03b1 were determined with a Bio-Plex Pro Cytokine Kit. Total NO-synthase activity was determined by the conversion of [\n                    <jats:sup>3<\/jats:sup>\n                    H]-arginine to [\n                    <jats:sup>3<\/jats:sup>\n                    H]-citrulline. Protein expression was analysed via Western blotting. Lipid peroxidation was evaluated by determining conjugated diene concentrations in the heart, while collagen content in the left ventricle was quantified by measuring hydroxyproline. Anti-HMGB1 treatment increased both NOS activity and endothelial NOS expression while reducing inducible NOS and NF\u03baB expression. It also decreased plasma IL-6 and TNF-\u03b1 levels, reduced lipid peroxidation, and lowered collagen content. The anti-HMGB1 protein demonstrated cardioprotection by modulating inflammation and oxidative stress, suggesting its potential as a therapeutic agent for MI and related cardiovascular conditions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-28160-w","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:53:56Z","timestamp":1764046436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of HMGB1 in ischemia\/reperfusion injury in a rat model of myocardial infarction"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-670X","authenticated-orcid":false,"given":"Martina","family":"Cebova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Barta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Bujnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pechanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"28160_CR1","unstructured":"WHO: Cardiovascular diseases, 2021 [online]. Dostupn\u00e9 na internete: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases (cvds) Last visited May 14th, 2025."},{"issue":"1","key":"28160_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Prim. 5(1), 56. https:\/\/doi.org\/10.1038\/s41572-019-0106-z (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"28160_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","volume":"45","author":"MA Matter","year":"2024","unstructured":"Matter, M. A. et al. Inflammation in acute myocardial infarction: The good, the bad and the ugly. Eur. Heart J. 45(2), 89\u2013103. https:\/\/doi.org\/10.1093\/eurheartj\/ehad486 (2024).","journal-title":"Eur. Heart J."},{"issue":"2","key":"28160_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cells11020216","volume":"11","author":"E Foglio","year":"2022","unstructured":"Foglio, E., Pellegrini, L., Russo, M. A. & Limana, F. HMGB1-mediated activation of the inflammatory-reparative response following myocardial infarction. Cells 11(2), 216. https:\/\/doi.org\/10.3390\/cells11020216 (2022).","journal-title":"Cells"},{"issue":"21","key":"28160_CR5","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.3390\/ijms21217948","volume":"21","author":"E Chikhirzhina","year":"2020","unstructured":"Chikhirzhina, E., Starkova, T., Beljajev, A., Polyanichko, A. & Tomilin, A. Functional diversity of non-histone chromosomal protein HmgB1. Int. J. Mol. Sci. 21(21), 7948. https:\/\/doi.org\/10.3390\/ijms21217948 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"28160_CR6","doi-asserted-by":"publisher","first-page":"111555","DOI":"10.1016\/j.biopha.2021.111555","volume":"139","author":"A Wahid","year":"2021","unstructured":"Wahid, A., Chen, W., Wang, X. & Tang, X. High-mobility group box 1 serves as an inflammation driver of cardiovascular disease. Biomed. Pharmacother. 139, 111555. https:\/\/doi.org\/10.1016\/j.biopha.2021.111555 (2021).","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"28160_CR7","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1111\/cts.13630","volume":"16","author":"A Wahid","year":"2023","unstructured":"Wahid, A. et al. Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure. Clin. Transl. Sci. 16(11), 2299\u20132309. https:\/\/doi.org\/10.1111\/cts.13630 (2023).","journal-title":"Clin. Transl. Sci."},{"issue":"14 Suppl","key":"28160_CR8","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1161\/CIRCULATIONAHA.107.757443","volume":"118","author":"K Takahashi","year":"2008","unstructured":"Takahashi, K. et al. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 118(14 Suppl), S106\u2013S114. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.757443 (2008).","journal-title":"Circulation"},{"issue":"3","key":"28160_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvn291","volume":"81","author":"T Kohno","year":"2009","unstructured":"Kohno, T. et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc. Res. 81(3), 565\u2013573. https:\/\/doi.org\/10.1093\/cvr\/cvn291 (2009).","journal-title":"Cardiovasc. Res."},{"issue":"25","key":"28160_CR10","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1161\/CIRCULATIONAHA.108.769331","volume":"117","author":"M Andrassy","year":"2008","unstructured":"Andrassy, M. et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117(25), 3216\u20133226. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.769331 (2008).","journal-title":"Circulation"},{"issue":"3","key":"28160_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.surg.2010.07.002","volume":"149","author":"AM Abarbanell","year":"2011","unstructured":"Abarbanell, A. M. et al. Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia\/reperfusion injury. Surgery 149(3), 329\u2013335. https:\/\/doi.org\/10.1016\/j.surg.2010.07.002 (2011).","journal-title":"Surgery"},{"issue":"5","key":"28160_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s00540-013-1584-x","volume":"27","author":"S Nishiike","year":"2013","unstructured":"Nishiike, S., Hiramatsu, T., Shiraishi, M., Ueda, Y. & Tsuchida, H. Relationship between vascular reactivity and expression of HMGB1 in a rat model of septic aorta. J. Anesth. 27(5), 684\u2013692. https:\/\/doi.org\/10.1007\/s00540-013-1584-x (2013).","journal-title":"J. Anesth."},{"issue":"9","key":"28160_CR13","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/molecules24091682","volume":"24","author":"M Kosutova","year":"2019","unstructured":"Kosutova, M., Pechanova, O., Barta, A., Franova, S. & Cebova, M. Different adaptive NO-dependent mechanisms in normal and hypertensive conditions. Molecules (Basel, Switzerland) 24(9), 1682. https:\/\/doi.org\/10.3390\/molecules24091682 (2019).","journal-title":"Molecules (Basel, Switzerland)"},{"key":"28160_CR14","doi-asserted-by":"publisher","first-page":"8156594","DOI":"10.1155\/2017\/8156594","volume":"2017","author":"M Cebova","year":"2017","unstructured":"Cebova, M., Klimentova, J., Janega, P. & Pechanova, O. Effect of bioactive compound of Aronia melanocarpa on cardiovascular system in experimental hypertension. Oxid. Med. Cell. Longev. 2017, 8156594. https:\/\/doi.org\/10.1155\/2017\/8156594 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"28160_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0009-9120(96)00003-6","volume":"29","author":"GK Reddy","year":"1996","unstructured":"Reddy, G. K. & Enwemeka, C. S. A simplified method for the analysis of hydroxyproline in biological tissues. Clin. Biochem. 29(3), 225\u2013229. https:\/\/doi.org\/10.1016\/0009-9120(96)00003-6 (1996).","journal-title":"Clin. Biochem."},{"issue":"4","key":"28160_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/01.res.44.4.503","volume":"44","author":"MA Pfeffer","year":"1979","unstructured":"Pfeffer, M. A. et al. Myocardial infarct size and ventricular function in rats. Circ. Res. 44(4), 503\u2013512. https:\/\/doi.org\/10.1161\/01.res.44.4.503 (1979).","journal-title":"Circ. Res."},{"issue":"1","key":"28160_CR17","doi-asserted-by":"publisher","first-page":"e5511","DOI":"10.1590\/1414-431X20165511","volume":"50","author":"R Aires","year":"2017","unstructured":"Aires, R., Pimentel, E. B., Forechi, L., Dantas, E. M. & Mill, J. G. Time course of changes in heart rate and blood pressure variability in rats with myocardial infarction. Braz. J. Med. Biol. Res. 50(1), e5511. https:\/\/doi.org\/10.1590\/1414-431X20165511 (2017).","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"9","key":"28160_CR18","doi-asserted-by":"publisher","first-page":"0910101","DOI":"10.1115\/1.4043867","volume":"141","author":"CM Witzenburg","year":"2019","unstructured":"Witzenburg, C. M. & Holmes, J. W. The impact of hemodynamic reflex compensation following myocardial infarction on subsequent ventricular remodeling. J. Biomech. Eng. 141(9), 0910101\u201309101010. https:\/\/doi.org\/10.1115\/1.4043867 (2019).","journal-title":"J. Biomech. Eng."},{"issue":"7","key":"28160_CR19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1253\/circj.72.1178","volume":"72","author":"S Oozawa","year":"2008","unstructured":"Oozawa, S. et al. Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ. J 72(7), 1178\u20131184. https:\/\/doi.org\/10.1253\/circj.72.1178 (2008).","journal-title":"Circ. J"},{"issue":"3","key":"28160_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cvr\/cvq373","volume":"89","author":"N Loukili","year":"2011","unstructured":"Loukili, N. et al. Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovasc. Res. 89(3), 586\u2013594. https:\/\/doi.org\/10.1093\/cvr\/cvq373 (2011).","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"28160_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.annemergmed.2015.11.013","volume":"68","author":"C Mueller","year":"2016","unstructured":"Mueller, C. et al. Multicenter evaluation of a 0-hour\/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann. Emerg. Med. 68(1), 76-87.e4. https:\/\/doi.org\/10.1016\/j.annemergmed.2015.11.013 (2016).","journal-title":"Ann. Emerg. Med."},{"key":"28160_CR22","unstructured":"Bujnova, K., Barta, A. & Cebova, M. Impact of high-fat diet on biochemical changes following experimental myocardial infarction. (Under review)."},{"key":"28160_CR23","doi-asserted-by":"publisher","first-page":"131800","DOI":"10.1016\/j.ijcard.2024.131800","volume":"400","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Aucubin protects against myocardial ischemia-reperfusion injury by regulating STAT3\/NF-\u03baB\/HMGB-1 pathway. Int. J. Cardiol. 400, 131800. https:\/\/doi.org\/10.1016\/j.ijcard.2024.131800 (2024).","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"28160_CR24","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.3390\/ijms24076497","volume":"24","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Zhang, D. & Yin, D. Pathophysiological effects of various interleukins on primary cell types in common heart disease. Int. J. Mol. Sci. 24(7), 6497. https:\/\/doi.org\/10.3390\/ijms24076497 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"28160_CR25","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.redox.2021.101890","volume":"41","author":"Q Zhou","year":"2021","unstructured":"Zhou, Q. et al. Endothelial specific deletion of HMGB1 increases blood pressure and retards ischemia recovery through eNOS and ROS pathway in mice. Redox Biol. 41, 101890. https:\/\/doi.org\/10.1016\/j.redox.2021.101890 (2021).","journal-title":"Redox Biol."},{"issue":"3","key":"28160_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","volume":"141","author":"D Musumeci","year":"2014","unstructured":"Musumeci, D., Roviello, G. N. & Montesarchio, D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol. Ther. 141(3), 347\u2013357. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.11.001 (2014).","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"28160_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang, H. et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J. Exp. Med. 212(1), 5\u201314. https:\/\/doi.org\/10.1084\/jem.20141318 (2015).","journal-title":"J. Exp. Med."},{"key":"28160_CR28","doi-asserted-by":"publisher","first-page":"675731","DOI":"10.3389\/fimmu.2021.675731","volume":"12","author":"A Teo Hansen Seln\u00f8","year":"2021","unstructured":"Teo Hansen Seln\u00f8, A. et al. High mobility group box 1 (HMGB1) induces toll-like receptor 4-mediated production of the immunosuppressive protein galectin-9 in human cancer cells. Front. Immunol. 12, 675731. https:\/\/doi.org\/10.3389\/fimmu.2021.675731 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"28160_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10020-018-0023-8","volume":"24","author":"M He","year":"2018","unstructured":"He, M., Bianchi, M. E., Coleman, T. R., Tracey, K. J. & Al-Abed, Y. Exploring the biological functional mechanism of the HMGB1\/TLR4\/MD-2 complex by surface plasmon resonance. Mol. Med. 24(1), 21. https:\/\/doi.org\/10.1186\/s10020-018-0023-8 (2018).","journal-title":"Mol. Med."},{"key":"28160_CR30","doi-asserted-by":"publisher","first-page":"115338","DOI":"10.1016\/j.biopha.2023.115338","volume":"166","author":"J Wei","year":"2023","unstructured":"Wei, J., Zhang, Y., Li, H., Wang, F. & Yao, S. Toll-like receptor 4: A potential therapeutic target for multiple human diseases. Biomed. Pharmacother. 166, 115338. https:\/\/doi.org\/10.1016\/j.biopha.2023.115338 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"3\u20134","key":"28160_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","volume":"26","author":"A Murao","year":"2021","unstructured":"Murao, A., Aziz, M., Wang, H., Brenner, M. & Wang, P. Release mechanisms of major DAMPs. Apoptosis Int. J. Program. Cell Death 26(3\u20134), 152\u2013162. https:\/\/doi.org\/10.1007\/s10495-021-01663-3 (2021).","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"issue":"10","key":"28160_CR32","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1038\/s44319-025-00444-2","volume":"26","author":"TE Schultz","year":"2025","unstructured":"Schultz, T. E. et al. TLR4 endocytosis and endosomal TLR4 signaling are distinct and independent outcomes of TLR4 activation. EMBO Rep. 26(10), 2740\u20132766. https:\/\/doi.org\/10.1038\/s44319-025-00444-2 (2025).","journal-title":"EMBO Rep."},{"issue":"12","key":"28160_CR33","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1161\/ATVBAHA.120.315151","volume":"40","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Internalization of HMGB1 (high mobility group box 1) promotes angiogenesis in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 40(12), 2922\u20132940. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315151 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"28160_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","volume":"128","author":"JS Burchfield","year":"2013","unstructured":"Burchfield, J. S., Xie, M. & Hill, J. A. Pathological ventricular remodeling: mechanisms: Part 1 of 2. Circulation 128(4), 388\u2013400. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001878 (2013).","journal-title":"Circulation"},{"key":"28160_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.trsl.2019.03.001","volume":"209","author":"S Park","year":"2019","unstructured":"Park, S., Nguyen, N. B., Pezhouman, A. & Ardehali, R. Cardiac fibrosis: Potential therapeutic targets. Transl. Res. J. Lab. Clin. Med. 209, 121\u2013137. https:\/\/doi.org\/10.1016\/j.trsl.2019.03.001 (2019).","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"28160_CR36","doi-asserted-by":"publisher","first-page":"117388","DOI":"10.1016\/j.jep.2023.117388","volume":"320","author":"G Zhang","year":"2024","unstructured":"Zhang, G. et al. Buyang Huanwu Decoction suppresses cardiac inflammation and fibrosis in mice after myocardial infarction through inhibition of the TLR4 signalling pathway. J. Ethnopharmacol. 320, 117388. https:\/\/doi.org\/10.1016\/j.jep.2023.117388 (2024).","journal-title":"J. Ethnopharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28160-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:45:22Z","timestamp":1766580322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28160-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28160"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28160-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44440"}}